Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00792675 · ClinicalTrials.gov registry record · NA

Effect of Exercise on the Disease Activity of Rheumatoid Arthritis

A NA study of Rheumatoid Arthritis, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT00792675: Completed NA study of Rheumatoid Arthritis, sponsored by University of Nebraska.

NCT00792675 is a NA study of Rheumatoid Arthritis that has completed, run by University of Nebraska. The registered enrollment target is 55 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00792675, a NA study of Rheumatoid Arthritis, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effect of exercise on the number of swollen and tender joints associated with rheumatoid arthritis after a 12 week exercise program of treadmill walking and weightlifting.

Conditions Studied

Interventions

  • OTHER Aerobic and resistance exercise training

Study Locations (1)

Nebraska

  • Physical Activity Lab, University of Nebraska Omaha - Omaha

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2003-01-01
Est. Completion 2006-11-01
Phase NA
University of Nebraska

407 total trials

What the finished NCT00792675 record still lists

NCT00792675 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Aerobic and resistance exercise training is the first listed.

NCT00792675 reports a single indexed study location in Nebraska.

Frequently Asked Questions

What is clinical trial NCT00792675 about?

NCT00792675 is a clinical study titled "Effect of Exercise on the Disease Activity of Rheumatoid Arthritis". This study will evaluate the effect of exercise on the number of swollen and tender joints associated with rheumatoid arthritis after a 12 week exercise program of treadmill walking and weightlifting.

What is the current status of trial NCT00792675?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2003-01-01. Estimated completion is 2006-11-01.

What conditions does trial NCT00792675 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT00792675?

The interventions under investigation include: Aerobic and resistance exercise training (OTHER).

Who is sponsoring clinical trial NCT00792675?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00792675 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00792675's enrollment target sits among peer trials

55 136th of 197 higher than 61 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01638676 · 55 participants · Phase 1

    A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

  • NCT01906385 · 55 participants · Phase 1

    Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • NCT03007030 · 55 participants · Phase 2

    Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

  • NCT03152058 · 55 participants · Phase 2

    IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00792675, the US trial registry maintained by the National Library of Medicine. NCT00792675 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.